Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2021

15.06.2021 | Review article

Diabetic Foot scientific activities in Endocrinology and Metabolism Research Institute

verfasst von: Maryam Aalaa, Mahnaz Sanjari, Ensieh Nasli Esfahani, Rash Atlasi, Bagher Larijani, Mohammad Reza Mohajeri-Tehrani, Neda Mehrdad, Mohammad Reza Amini

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Diabetic Foot (DF) as a common complication of Diabetes should be intensive intervention for prevention, management and rehabilitation. In this regard, Diabetes Research Center of Endocrinology and Metabolism Research Institute (EMRI) of Tehran University of Medical Sciences (TUMS) considered DF as a priority research area to investigate multidimensional aspects of DF care. We are intended to summarize DF research studies affiliated to the EMRI for over the last two decades.

Methods

Three Electronic databases including Web of Science, PubMed, and Scopus were searched until January 2020 to find articles about DF published affiliated to EMRI. The main concepts of search strategies were “diabetes”, “Foot”. 115 documents retrieved from these databases which screened for inclusion and exclusion criteria. The visualization of the network of co-authorship of authors and co-occurrence of keywords was illustrated and documents were analyzed for content according to the Main areas of DF Research studies.

Result

64 related documents including original articles, reviews, letters, notes, and book chapter have included to this study. According to the objectives of the retrieved studies, DF documents and research studies categorized in the two main groups including DF prevention, classification and risk stratification in addition management of DF.

Conclusion

Despite conducted research and educational activities in DF prevention and management, the following topics would be considered as well: effective offloading treatment, correcting the nutritional status for improving wound healing and novel educational strategies for diabetic foot multi-disciplinary team.
Literatur
1.
Zurück zum Zitat Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32:45–74.CrossRef Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32:45–74.CrossRef
2.
Zurück zum Zitat Bakker K, Apelqvist J, Lipsky B, Van Netten J, Schaper N, Foot IWGotD. The, . IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2015;2016(32):2–6. Bakker K, Apelqvist J, Lipsky B, Van Netten J, Schaper N, Foot IWGotD. The, . IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2015;2016(32):2–6.
3.
Zurück zum Zitat Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.CrossRef Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.CrossRef
4.
Zurück zum Zitat Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Pajouhi M, Fard AS, Amini MR, Larijani B. Iranian diabetic foot research network. Adv Skin Wound Care. 2010;23(10):450–4.CrossRef Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Pajouhi M, Fard AS, Amini MR, Larijani B. Iranian diabetic foot research network. Adv Skin Wound Care. 2010;23(10):450–4.CrossRef
5.
Zurück zum Zitat Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519–24.CrossRef Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519–24.CrossRef
6.
Zurück zum Zitat Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJ. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care. 2018;41(4):645–52.CrossRef Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJ. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care. 2018;41(4):645–52.CrossRef
7.
Zurück zum Zitat Apelqvist J. The diabetic foot syndrome today: a pandemic uprise. The Diabetic Foot Syndrome. 26: Karger Publishers; 2018. p. 1–18. Apelqvist J. The diabetic foot syndrome today: a pandemic uprise. The Diabetic Foot Syndrome. 26: Karger Publishers; 2018. p. 1–18.
8.
Zurück zum Zitat Blume P, Wu S. Updating the Diabetic Foot Treatment Algorithm: Recommendations on Treatment Using Advanced Medicine and Therapies. Wounds: a compendium of clinical research and practice. 2018;30(2):29–35. Blume P, Wu S. Updating the Diabetic Foot Treatment Algorithm: Recommendations on Treatment Using Advanced Medicine and Therapies. Wounds: a compendium of clinical research and practice. 2018;30(2):29–35.
9.
Zurück zum Zitat Aalaa M, Sanjari M, Mohajeri-Tehrani MR, Mehrdad N, Amini MR. A multidisciplinary team approach in Iranian diabetic foot research group. J Diabetes Metab Disord. 2019;18(2):721–3.CrossRef Aalaa M, Sanjari M, Mohajeri-Tehrani MR, Mehrdad N, Amini MR. A multidisciplinary team approach in Iranian diabetic foot research group. J Diabetes Metab Disord. 2019;18(2):721–3.CrossRef
10.
Zurück zum Zitat Aalaa M, Sanjari M, Shahbazi S, Shayeganmehr Z, Abooeirad M, Amini MR, et al. Diabetic foot workshop: Improving technical and educational skills for nurses. Med J Islam Repub Iran. 2017;31:8.CrossRef Aalaa M, Sanjari M, Shahbazi S, Shayeganmehr Z, Abooeirad M, Amini MR, et al. Diabetic foot workshop: Improving technical and educational skills for nurses. Med J Islam Repub Iran. 2017;31:8.CrossRef
11.
Zurück zum Zitat Shokoohi M, Nedjat S, Majdzadeh R. A social network analysis on clinical education of diabetic foot. J Diabetes Metab Disord. 2013;12(1). Shokoohi M, Nedjat S, Majdzadeh R. A social network analysis on clinical education of diabetic foot. J Diabetes Metab Disord. 2013;12(1).
12.
Zurück zum Zitat Madarshahian F, Hassanabadi M, Koshniat Nikoo M. Cognitive status and foot self care practice in overweight diabetics, engaged in different levels of physical activity. J Diabetes Metab Disord. 2014;13(1). Madarshahian F, Hassanabadi M, Koshniat Nikoo M. Cognitive status and foot self care practice in overweight diabetics, engaged in different levels of physical activity. J Diabetes Metab Disord. 2014;13(1).
13.
Zurück zum Zitat Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol. 2005;5.
14.
Zurück zum Zitat Abri H, Aalaa M, Sanjari M, Amini MR, Mohajeri-Tehrani MR, Larijani B. Plantar pressure distribution in diverse stages of diabetic neuropathy. J Diabetes Metab Disord. 2019;18(1):33–9.CrossRef Abri H, Aalaa M, Sanjari M, Amini MR, Mohajeri-Tehrani MR, Larijani B. Plantar pressure distribution in diverse stages of diabetic neuropathy. J Diabetes Metab Disord. 2019;18(1):33–9.CrossRef
15.
Zurück zum Zitat Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Madani SP, Heshmat R, Larijani B. The Prevalence of Diabetic Peripheral Neuropathy and Related Factors. Iran J Public Health. 2011;40(3):55–62.PubMedPubMedCentral Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Madani SP, Heshmat R, Larijani B. The Prevalence of Diabetic Peripheral Neuropathy and Related Factors. Iran J Public Health. 2011;40(3):55–62.PubMedPubMedCentral
16.
Zurück zum Zitat Fateh HR, Madani SP, Heshmat R, Larijani B. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. J Diabetes Metab Disord. 2016;15. Fateh HR, Madani SP, Heshmat R, Larijani B. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. J Diabetes Metab Disord. 2016;15.
17.
Zurück zum Zitat Forouzandeh F, Ahari AA, Abolhasani F, Larijani B. Comparison of different screening tests for detecting diabetic foot neuropathy. Acta Neurol Scand. 2005;112(6):409–13.CrossRef Forouzandeh F, Ahari AA, Abolhasani F, Larijani B. Comparison of different screening tests for detecting diabetic foot neuropathy. Acta Neurol Scand. 2005;112(6):409–13.CrossRef
18.
Zurück zum Zitat Abdollahi M, Farzamfar B, Salari P, Khorram KHR, Larijani B, Farhadi M, et al. Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARS (TM)), a new phytotherapeutic drug for wound healing in rodents. Daru. 2008;16:7–14. Abdollahi M, Farzamfar B, Salari P, Khorram KHR, Larijani B, Farhadi M, et al. Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARS (TM)), a new phytotherapeutic drug for wound healing in rodents. Daru. 2008;16:7–14.
19.
Zurück zum Zitat Farzamfar B, Abdollahi M, Ka’abinejadian S, Heshmat R, Shahhosseiny MH, Novitsky YA, et al. Sub-chronic toxicity study of a novel herbal-based formulation (Semelil) on dogs. Daru. 2008;16:15–9. Farzamfar B, Abdollahi M, Ka’abinejadian S, Heshmat R, Shahhosseiny MH, Novitsky YA, et al. Sub-chronic toxicity study of a novel herbal-based formulation (Semelil) on dogs. Daru. 2008;16:15–9.
20.
Zurück zum Zitat Khorram KHR, Sadeghi B, Heshmat R, Abdollahi M, Salari P, Farzamfar B, et al. In vivo and in vitro genotoxicity studies of Semelil (ANGIPARS (TM)). Daru. 2008;16:20–4. Khorram KHR, Sadeghi B, Heshmat R, Abdollahi M, Salari P, Farzamfar B, et al. In vivo and in vitro genotoxicity studies of Semelil (ANGIPARS (TM)). Daru. 2008;16:20–4.
21.
Zurück zum Zitat Heshmat R, Mohammad K, Mohajeri TMR, Tabatabaie MO, Keshtkar AA, Gharibdoust F, et al. Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARS (TM)) in patients with diabetic foot ulcer: A phase I clinical. Daru. 2008;16:25–30. Heshmat R, Mohammad K, Mohajeri TMR, Tabatabaie MO, Keshtkar AA, Gharibdoust F, et al. Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARS (TM)) in patients with diabetic foot ulcer: A phase I clinical. Daru. 2008;16:25–30.
22.
Zurück zum Zitat Masoompour SM, Bagheri MH, Borhani HA, Novitsky YA, Sadeghi B, Gharibdoust F, et al. Effect of ANGIPARS (TM), a new herbal drug on diabetic foot ulcer: A phase 2 clinical study. Daru. 2008;16:31–4. Masoompour SM, Bagheri MH, Borhani HA, Novitsky YA, Sadeghi B, Gharibdoust F, et al. Effect of ANGIPARS (TM), a new herbal drug on diabetic foot ulcer: A phase 2 clinical study. Daru. 2008;16:31–4.
23.
Zurück zum Zitat Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar OG, Mohammad K, et al. Effects of intravenous Semelil (ANGIPARS (TM)) on diabetic foot ulcers healing: A multicenter clinical trial. Daru-Journal of Faculty of Pharmacy. 2008;16:35–40. Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar OG, Mohammad K, et al. Effects of intravenous Semelil (ANGIPARS (TM)) on diabetic foot ulcers healing: A multicenter clinical trial. Daru-Journal of Faculty of Pharmacy. 2008;16:35–40.
24.
Zurück zum Zitat Bahrami A, Kamali K, Ali-Asgharzadeh A, Hosseini P, Heshmat R, Khorram KHR, et al. Clinical application of oral form of ANGIPARS (TM) and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial. Daru. 2008;16:41–8. Bahrami A, Kamali K, Ali-Asgharzadeh A, Hosseini P, Heshmat R, Khorram KHR, et al. Clinical application of oral form of ANGIPARS (TM) and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial. Daru. 2008;16:41–8.
25.
Zurück zum Zitat Shamimi NK, HESHMAT R, Karimian R, Nasli E, Novitsky Y, Farhadi M, et al. Intravenous Semelil (ANGIPARS™) as a novel therapy for pressure Ulcers: A randomized clinical trial. 2008. Shamimi NK, HESHMAT R, Karimian R, Nasli E, Novitsky Y, Farhadi M, et al. Intravenous Semelil (ANGIPARS™) as a novel therapy for pressure Ulcers: A randomized clinical trial. 2008.
26.
Zurück zum Zitat Shamimi NK, Karimian R, Nasli E, Kamali K, Chaman R, Farhadi M, et al. Topical application of Semelil (ANGIPARS™) in treatment of pressure ulcers: A randomized clinical trial. 2008. Shamimi NK, Karimian R, Nasli E, Kamali K, Chaman R, Farhadi M, et al. Topical application of Semelil (ANGIPARS™) in treatment of pressure ulcers: A randomized clinical trial. 2008.
27.
Zurück zum Zitat Ebrahimi M, Bakhshayeshi S, Heshmat R, Shahbazi S, Aala M, Peimani M, et al. Post marketing surveillance on safety and effectiveness of ANGIPARS in treatment of diabetic foot ulcers. Daru. 2009;17:45–9. Ebrahimi M, Bakhshayeshi S, Heshmat R, Shahbazi S, Aala M, Peimani M, et al. Post marketing surveillance on safety and effectiveness of ANGIPARS in treatment of diabetic foot ulcers. Daru. 2009;17:45–9.
28.
Zurück zum Zitat Kaviani A, Djavid GE, Ataie-Fashtami L, Fateh M, Ghodsi M, Salami M, et al. A Randomized Clinical Trial on the Effect of Low-Level Laser Therapy on Chronic Diabetic Foot Wound Healing: A Preliminary Report. Photomed Laser Surg. 2011;29(2):109–14.CrossRef Kaviani A, Djavid GE, Ataie-Fashtami L, Fateh M, Ghodsi M, Salami M, et al. A Randomized Clinical Trial on the Effect of Low-Level Laser Therapy on Chronic Diabetic Foot Wound Healing: A Preliminary Report. Photomed Laser Surg. 2011;29(2):109–14.CrossRef
29.
Zurück zum Zitat Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59(7):365–73.CrossRef Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59(7):365–73.CrossRef
30.
Zurück zum Zitat Shojaiefard A, Khorgami Z, Larijani B. Septic diabetic foot is not necessarily an indication for amputation. J Foot Ankle Surg. 2008;47(5):419–23.CrossRef Shojaiefard A, Khorgami Z, Larijani B. Septic diabetic foot is not necessarily an indication for amputation. J Foot Ankle Surg. 2008;47(5):419–23.CrossRef
31.
Zurück zum Zitat Rouhipour N, Hayatshahi A, Nikoo MK, Yazdi NM, Heshmat R, Qorbani M, et al. Clinical microbiology study of diabetic foot ulcer in Iran; pathogens and antibacterial susceptibility. Afr J Microbiol Res. 2012;6(27):5601–8. Rouhipour N, Hayatshahi A, Nikoo MK, Yazdi NM, Heshmat R, Qorbani M, et al. Clinical microbiology study of diabetic foot ulcer in Iran; pathogens and antibacterial susceptibility. Afr J Microbiol Res. 2012;6(27):5601–8.
32.
Zurück zum Zitat Mohseni S, Aalaa M, Atlasi R, Tehrani MRM, Sanjari M, Amini MR. The effectiveness of negative pressure wound therapy as a novel management of diabetic foot ulcers: an overview of systematic reviews. J Diabetes Metab Disord. 2019:1–17. Mohseni S, Aalaa M, Atlasi R, Tehrani MRM, Sanjari M, Amini MR. The effectiveness of negative pressure wound therapy as a novel management of diabetic foot ulcers: an overview of systematic reviews. J Diabetes Metab Disord. 2019:1–17.
33.
Zurück zum Zitat Mohajeri-Tehrani MR, Variji Z, Mohseni S, Firuz A, Annabestani Z, Zartab H, et al. Comparison of a Bioimplant Dressing With a Wet Dressing for the Treatment of Diabetic Foot Ulcers: A Randomized, Controlled Clinical Trial. Wounds-Compend Clin Res Pract. 2016;28(7):248–54. Mohajeri-Tehrani MR, Variji Z, Mohseni S, Firuz A, Annabestani Z, Zartab H, et al. Comparison of a Bioimplant Dressing With a Wet Dressing for the Treatment of Diabetic Foot Ulcers: A Randomized, Controlled Clinical Trial. Wounds-Compend Clin Res Pract. 2016;28(7):248–54.
34.
Zurück zum Zitat Mohammadzadeh L, Samedanifard SH, Keshavarzi A, Alimoghaddam K, Larijani B, Ghavamzadeh A, et al. Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb Ischaemia. Exp Clin Endocrinol Diabet. 2013;121(1):48–53.CrossRef Mohammadzadeh L, Samedanifard SH, Keshavarzi A, Alimoghaddam K, Larijani B, Ghavamzadeh A, et al. Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb Ischaemia. Exp Clin Endocrinol Diabet. 2013;121(1):48–53.CrossRef
35.
Zurück zum Zitat El Fattah AMA, Shaaban M, Gawish H, El Mashad N, Dawood AED. Effect of ultrasound-assisted debridement on wound healing and infection outcomes in diabetic foot. Menoufia Medical Journal. 2018;31(2):462. El Fattah AMA, Shaaban M, Gawish H, El Mashad N, Dawood AED. Effect of ultrasound-assisted debridement on wound healing and infection outcomes in diabetic foot. Menoufia Medical Journal. 2018;31(2):462.
36.
Zurück zum Zitat Larijani B, Afshari M, Fadaei M, Pajouhi M, Bastanhagh M, Baradar JR. Effect of local epidermal growth factor on wound healing in diabetic foot. Iranian Journal of Endocrinology and Metabolism. 2003;5(2):107–10. Larijani B, Afshari M, Fadaei M, Pajouhi M, Bastanhagh M, Baradar JR. Effect of local epidermal growth factor on wound healing in diabetic foot. Iranian Journal of Endocrinology and Metabolism. 2003;5(2):107–10.
37.
Zurück zum Zitat Larijani B, Hasani RS. Overview of diabetic foot; novel treatments in diabetic foot ulcer. Daru. 2008;16:1–6. Larijani B, Hasani RS. Overview of diabetic foot; novel treatments in diabetic foot ulcer. Daru. 2008;16:1–6.
38.
Zurück zum Zitat Mohajeri-Tehrani MR, Aalaa M, Mohseni SH, Anabestani Z, Larijani B. Multidisciplinary Approach in Diabetic Foot Care in Iran (New Concept). Iran J Public Health. 2012;41(6):103–4.PubMedPubMedCentral Mohajeri-Tehrani MR, Aalaa M, Mohseni SH, Anabestani Z, Larijani B. Multidisciplinary Approach in Diabetic Foot Care in Iran (New Concept). Iran J Public Health. 2012;41(6):103–4.PubMedPubMedCentral
39.
Zurück zum Zitat Malazy OT, Mohajeri-Tehrani MR, Pajouhi M, Fard AS, Amini MR, Larijani B. Iranian Diabetic Foot Research Network. Adv Skin Wound Care. 2010;23(10):450–4.CrossRef Malazy OT, Mohajeri-Tehrani MR, Pajouhi M, Fard AS, Amini MR, Larijani B. Iranian Diabetic Foot Research Network. Adv Skin Wound Care. 2010;23(10):450–4.CrossRef
Metadaten
Titel
Diabetic Foot scientific activities in Endocrinology and Metabolism Research Institute
verfasst von
Maryam Aalaa
Mahnaz Sanjari
Ensieh Nasli Esfahani
Rash Atlasi
Bagher Larijani
Mohammad Reza Mohajeri-Tehrani
Neda Mehrdad
Mohammad Reza Amini
Publikationsdatum
15.06.2021
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2021
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00823-1

Weitere Artikel der Ausgabe 2/2021

Journal of Diabetes & Metabolic Disorders 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.